{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:01Z","timestamp":1792097341693,"version":"4.4.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460570"],"award-info":[{"award-number":["82460570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03382-8","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:32:55Z","timestamp":1788845575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles in gastric cancer: biological functions, clinical applications, and engineering strategies"],"prefix":"10.1007","volume":"43","author":[{"given":"Xuewei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"3","key":"3382_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"10494","key":"3382_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","volume":"405","author":"R Sundar","year":"2025","unstructured":"Sundar R, Nakayama I, Markar SR, et al. Gastric cancer. Lancet. 2025;405(10494):2087\u2013102. https:\/\/doi.org\/10.1016\/S0140-6736(25)00052-2.","journal-title":"Lancet"},{"issue":"3","key":"3382_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.hoc.2024.01.003","volume":"38","author":"EE Stroobant","year":"2024","unstructured":"Stroobant EE, Strong VE. Advances in gastric cancer surgical management. Hematol Oncol Clin North Am. 2024;38(3):547\u201357. https:\/\/doi.org\/10.1016\/j.hoc.2024.01.003.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3382_CR4","doi-asserted-by":"publisher","first-page":"215823","DOI":"10.1016\/j.canlet.2022.215823","volume":"548","author":"Q Tang","year":"2022","unstructured":"Tang Q, Yang S, He G, et al. Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy. Cancer Lett. 2022;548:215823. https:\/\/doi.org\/10.1016\/j.canlet.2022.215823.","journal-title":"Cancer Lett"},{"issue":"19","key":"3382_CR5","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammond JR, et al. Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412\u201320. https:\/\/doi.org\/10.1016\/S0021-9258(18)48095-7.","journal-title":"J Biol Chem"},{"issue":"2","key":"3382_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/ijms17020170","volume":"17","author":"H Kalra","year":"2016","unstructured":"Kalra H, Drummen GPC, Mathivanan S. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci. 2016;17(2):170. https:\/\/doi.org\/10.3390\/ijms17020170.","journal-title":"Int J Mol Sci"},{"key":"3382_CR7","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. https:\/\/doi.org\/10.3402\/jev.v4.27066.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"3382_CR8","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"3382_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12272-022-01387-1","volume":"45","author":"SB Kim","year":"2022","unstructured":"Kim SB. Function and therapeutic development of exosomes for cancer therapy. Arch Pharm Res. 2022;45(5):295\u2013308. https:\/\/doi.org\/10.1007\/s12272-022-01387-1.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"3382_CR10","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/ijms24043061","volume":"24","author":"XX Li","year":"2023","unstructured":"Li XX, Yang LX, Wang C, et al. The roles of exosomal proteins: classification, function, and applications. Int J Mol Sci. 2023;24(4):3061. https:\/\/doi.org\/10.3390\/ijms24043061.","journal-title":"Int J Mol Sci"},{"key":"3382_CR11","doi-asserted-by":"publisher","first-page":"20384","DOI":"10.3402\/jev.v2i0.20384","volume":"2","author":"DK Kim","year":"2013","unstructured":"Kim DK, Kang B, Kim OY, et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles. 2013;2:20384. https:\/\/doi.org\/10.3402\/jev.v2i0.20384.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"3382_CR12","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/microorganisms8111776","volume":"8","author":"M Hinata","year":"2020","unstructured":"Hinata M, Kunita A, Abe H, et al. Exosomes of Epstein-Barr virus-associated gastric carcinoma suppress dendritic cell maturation. Microorganisms. 2020;8(11):1776. https:\/\/doi.org\/10.3390\/microorganisms8111776.","journal-title":"Microorganisms"},{"issue":"1","key":"3382_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1186\/s12967-024-05611-y","volume":"22","author":"H Li","year":"2024","unstructured":"Li H, Chen X, Zheng S, et al. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer. J Transl Med. 2024;22(1):821. https:\/\/doi.org\/10.1186\/s12967-024-05611-y.","journal-title":"J Transl Med"},{"issue":"2","key":"3382_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7150\/jca.102360","volume":"16","author":"J Qin","year":"2025","unstructured":"Qin J, Yang J, Cui H, et al. Exosomal miR-552-5p regulates the role of NK cells in EMT of gastric cancer via the PD-1\/PD-L1 axis. J Cancer. 2025;16(2):406\u201316. https:\/\/doi.org\/10.7150\/jca.102360.","journal-title":"J Cancer"},{"issue":"8","key":"3382_CR15","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.cmet.2024.05.013","volume":"36","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Wang Y, Chen G, et al. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. Cell Metab. 2024;36(8):1806\u2013e2211. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.013.","journal-title":"Cell Metab"},{"issue":"5164","key":"3382_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415\u201321. https:\/\/doi.org\/10.1126\/science.8197455.","journal-title":"Science"},{"issue":"1","key":"3382_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23(1):49. https:\/\/doi.org\/10.1186\/s12943-024-01966-4.","journal-title":"Mol Cancer"},{"key":"3382_CR18","doi-asserted-by":"publisher","first-page":"156137","DOI":"10.1016\/j.phymed.2024.156137","volume":"135","author":"J Yi","year":"2024","unstructured":"Yi J, Ye Z, Xu H, et al. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Phytomedicine. 2024;135:156137. https:\/\/doi.org\/10.1016\/j.phymed.2024.156137.","journal-title":"Phytomedicine"},{"key":"3382_CR19","doi-asserted-by":"publisher","first-page":"217758","DOI":"10.1016\/j.canlet.2025.217758","volume":"626","author":"W Li","year":"2025","unstructured":"Li W, Wei H, Liu J, et al. Exosomal biglycan promotes gastric cancer progression via M2 polarization and CXCL10-mediated JAK\/STAT1 activation. Cancer Lett. 2025;626:217758. https:\/\/doi.org\/10.1016\/j.canlet.2025.217758.","journal-title":"Cancer Lett"},{"key":"3382_CR20","doi-asserted-by":"publisher","first-page":"154229","DOI":"10.1016\/j.phymed.2022.154229","volume":"103","author":"J Wu","year":"2022","unstructured":"Wu J, Yuan M, Shen J, et al. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes. Phytomedicine. 2022;103:154229. https:\/\/doi.org\/10.1016\/j.phymed.2022.154229.","journal-title":"Phytomedicine"},{"issue":"3","key":"3382_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13105-021-00813-0","volume":"77","author":"S Zheng","year":"2021","unstructured":"Zheng S, Liu Q, Liu T, et al. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered. J Physiol Biochem. 2021;77(3):355\u201363. https:\/\/doi.org\/10.1007\/s13105-021-00813-0.","journal-title":"J Physiol Biochem"},{"issue":"22","key":"3382_CR22","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.3390\/cancers14225532","volume":"14","author":"S Zheng","year":"2022","unstructured":"Zheng S, Liang Y, Tan Y, et al. Small tweaks, major changes: post-translational modifications that occur within M2 macrophages in the tumor microenvironment. Cancers (Basel). 2022;14(22):5532. https:\/\/doi.org\/10.3390\/cancers14225532.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3382_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41419-018-0465-5","volume":"9","author":"P Zheng","year":"2018","unstructured":"Zheng P, Luo Q, Wang W, et al. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional apolipoprotein E. Cell Death Dis. 2018;9(4):434. https:\/\/doi.org\/10.1038\/s41419-018-0465-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3382_CR24","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","volume":"10","author":"T Yu","year":"2019","unstructured":"Yu T, Gan S, Zhu Q, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 2019;10(1):4353. https:\/\/doi.org\/10.1038\/s41467-019-12384-2.","journal-title":"Nat Commun"},{"issue":"8","key":"3382_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/cac2.70034","volume":"45","author":"S Li","year":"2025","unstructured":"Li S, Zhou J, Wang S, et al. N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis. Cancer Commun (Lond). 2025;45(8):941\u201365. https:\/\/doi.org\/10.1002\/cac2.70034.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"3382_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00262-021-02991-8","volume":"71","author":"J Li","year":"2022","unstructured":"Li J, Sun L, Chen Y, et al. Gastric cancer-derived exosomal miR-135b-5p impairs the function of V\u03b39V\u03b42 T cells by targeting specificity protein 1. Cancer Immunol Immunother. 2022;71(2):311\u201325. https:\/\/doi.org\/10.1007\/s00262-021-02991-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"3382_CR27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4(5):594\u2013600. https:\/\/doi.org\/10.1038\/nm0598-594.","journal-title":"Nat Med"},{"issue":"6","key":"3382_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1158\/0008-5472.CAN-18-0779","volume":"79","author":"P Neviani","year":"2019","unstructured":"Neviani P, Wise PM, Murtadha M, et al. Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms. Cancer Res. 2019;79(6):1151\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0779.","journal-title":"Cancer Res"},{"issue":"10","key":"3382_CR29","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.7150\/thno.18752","volume":"7","author":"L Zhu","year":"2017","unstructured":"Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7(10):2732\u201345. https:\/\/doi.org\/10.7150\/thno.18752.","journal-title":"Theranostics"},{"key":"3382_CR30","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1038\/ncomms8164","volume":"6","author":"BH Sung","year":"2015","unstructured":"Sung BH, Ketova T, Hoshino D, et al. Directional cell movement through tissues is controlled by exosome secretion. Nat Commun. 2015;6:7164. https:\/\/doi.org\/10.1038\/ncomms8164.","journal-title":"Nat Commun"},{"issue":"1","key":"3382_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12951-021-00873-w","volume":"19","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen L, Ye X, et al. Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer. J Nanobiotechnol. 2021;19(1):133. https:\/\/doi.org\/10.1186\/s12951-021-00873-w.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"3382_CR32","doi-asserted-by":"publisher","first-page":"13497","DOI":"10.1002\/cam4.6007","volume":"12","author":"S Wu","year":"2023","unstructured":"Wu S, Tang C, Zhang QW, et al. Overexpression of RAB31 in gastric cancer is associated with released exosomes and increased tumor cell invasion and metastasis. Cancer Med. 2023;12(12):13497\u2013510. https:\/\/doi.org\/10.1002\/cam4.6007.","journal-title":"Cancer Med"},{"issue":"5","key":"3382_CR33","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/cas.14740","volume":"112","author":"X Chen","year":"2021","unstructured":"Chen X, Zhang S, Du K, et al. Gastric cancer-secreted exosomal X26nt increases angiogenesis and vascular permeability by targeting VE-cadherin. Cancer Sci. 2021;112(5):1839\u201352. https:\/\/doi.org\/10.1111\/cas.14740.","journal-title":"Cancer Sci"},{"key":"3382_CR34","doi-asserted-by":"publisher","first-page":"1440996","DOI":"10.3389\/fonc.2024.1440996","volume":"14","author":"H Yan","year":"2024","unstructured":"Yan H, Cai X, Zhang J, et al. Gastric cancer cell-derived exosomal miRNA-128-3p promotes angiogenesis by targeting SASH1. Front Oncol. 2024;14:1440996. https:\/\/doi.org\/10.3389\/fonc.2024.1440996.","journal-title":"Front Oncol"},{"issue":"12","key":"3382_CR35","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3390\/cimb44120419","volume":"44","author":"K Iha","year":"2022","unstructured":"Iha K, Sato A, Tsai HY, et al. Gastric cancer cell-derived exosomal GRP78 enhances angiogenesis upon stimulation of vascular endothelial cells. Curr Issues Mol Biol. 2022;44(12):6145\u201357. https:\/\/doi.org\/10.3390\/cimb44120419.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"3382_CR36","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175. https:\/\/doi.org\/10.1038\/s41467-025-57465-7.","journal-title":"Nat Commun"},{"issue":"3","key":"3382_CR37","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1159\/000493218","volume":"49","author":"J Wang","year":"2018","unstructured":"Wang J, Guan X, Zhang Y, et al. Exosomal miR-27a derived from gastric cancer cells regulates the transformation of fibroblasts into cancer-associated fibroblasts. Cell Physiol Biochem. 2018;49(3):869\u201383. https:\/\/doi.org\/10.1159\/000493218.","journal-title":"Cell Physiol Biochem"},{"key":"3382_CR38","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8:15016. https:\/\/doi.org\/10.1038\/ncomms15016.","journal-title":"Nat Commun"},{"issue":"1","key":"3382_CR39","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41467-023-37320-3","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Deng T, Liu R, et al. Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2023;14(1):1700. https:\/\/doi.org\/10.1038\/s41467-023-37320-3.","journal-title":"Nat Commun"},{"issue":"19","key":"3382_CR40","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2217\/nnm-2019-0053","volume":"14","author":"C Feng","year":"2019","unstructured":"Feng C, She J, Chen X, et al. Exosomal miR-196a-1 promotes gastric cancer cell invasion and metastasis by targeting SFRP1. Nanomed (Lond). 2019;14(19):2579\u201393. https:\/\/doi.org\/10.2217\/nnm-2019-0053.","journal-title":"Nanomed (Lond)"},{"issue":"1","key":"3382_CR41","doi-asserted-by":"publisher","first-page":"113613","DOI":"10.1016\/j.celrep.2023.113613","volume":"43","author":"A Yonemura","year":"2024","unstructured":"Yonemura A, Semba T, Zhang J, et al. Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment. Cell Rep. 2024;43(1):113613. https:\/\/doi.org\/10.1016\/j.celrep.2023.113613.","journal-title":"Cell Rep"},{"key":"3382_CR42","doi-asserted-by":"publisher","first-page":"112039","DOI":"10.1016\/j.cellsig.2025.112039","volume":"135","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang M, Gao X, et al. Gastric cancer-derived exosomal miR-196a-5p remodels the pre-metastatic niche for peritoneal dissemination. Cell Signal. 2025;135:112039. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112039.","journal-title":"Cell Signal"},{"issue":"1","key":"3382_CR43","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41419-025-07749-z","volume":"16","author":"C Dong","year":"2025","unstructured":"Dong C, Zhou Y, Shen X, et al. Tumor exosomal circPTBP3 drives gastric cancer peritoneal metastasis via mesothelial-mesenchymal transition. Cell Death Dis. 2025;16(1):444. https:\/\/doi.org\/10.1038\/s41419-025-07749-z.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3382_CR44","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/15384101.2020.1749467","volume":"19","author":"M Zhu","year":"2020","unstructured":"Zhu M, Zhang N, He S, et al. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle. 2020;19(10):1200\u201321. https:\/\/doi.org\/10.1080\/15384101.2020.1749467.","journal-title":"Cell Cycle"},{"issue":"1","key":"3382_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3892\/ijo.2018.4601","volume":"54","author":"M Wang","year":"2019","unstructured":"Wang M, Qiu R, Yu S, et al. Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p. Int J Oncol. 2019;54(1):326\u201338. https:\/\/doi.org\/10.3892\/ijo.2018.4601.","journal-title":"Int J Oncol"},{"key":"3382_CR46","doi-asserted-by":"publisher","first-page":"618899","DOI":"10.3389\/fcell.2021.618899","volume":"9","author":"MY Sun","year":"2021","unstructured":"Sun MY, Xu B, Wu QX, et al. Cisplatin-resistant gastric cancer cells promote the chemoresistance of cisplatin-sensitive cells via the exosomal RPS3-mediated PI3K-Akt-cofilin-1 signaling axis. Front Cell Dev Biol. 2021;9:618899. https:\/\/doi.org\/10.3389\/fcell.2021.618899.","journal-title":"Front Cell Dev Biol"},{"key":"3382_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fonc.2020.00492","volume":"10","author":"M Zhang","year":"2020","unstructured":"Zhang M, Fan Y, Che X, et al. 5-FU-induced upregulation of exosomal PD-L1 causes immunosuppression in advanced gastric cancer patients. Front Oncol. 2020;10:492. https:\/\/doi.org\/10.3389\/fonc.2020.00492.","journal-title":"Front Oncol"},{"key":"3382_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.freeradbiomed.2025.07.022","volume":"239","author":"X Dong","year":"2025","unstructured":"Dong X, Xu J, Zhang J, et al. Exosomes from tumor-associated neutrophils suppress ferroptosis and confer chemoresistance in gastric cancer via the miR-9-3p\/ACSL4 axis. Free Radic Biol Med. 2025;239:49\u201362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.07.022.","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"3382_CR49","doi-asserted-by":"publisher","first-page":"e2103222","DOI":"10.1002\/advs.202103222","volume":"9","author":"JJ Lai","year":"2022","unstructured":"Lai JJ, Chau ZL, Chen SY, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci (Weinh). 2022;9(15):e2103222. https:\/\/doi.org\/10.1002\/advs.202103222.","journal-title":"Adv Sci (Weinh)"},{"key":"3382_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88:487\u2013514. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111902.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"3382_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56. https:\/\/doi.org\/10.1186\/s12943-022-01509-9.","journal-title":"Mol Cancer"},{"issue":"11","key":"3382_CR52","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1111\/jcmm.15253","volume":"24","author":"X Liu","year":"2020","unstructured":"Liu X, Chu KM. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II\/III gastric cancer. J Cell Mol Med. 2020;24(11):6220\u201332. https:\/\/doi.org\/10.1111\/jcmm.15253.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3382_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-018-0817-x","volume":"17","author":"R Zhao","year":"2018","unstructured":"Zhao R, Zhang Y, Zhang X, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer. Mol Cancer. 2018;17(1):68. https:\/\/doi.org\/10.1186\/s12943-018-0817-x.","journal-title":"Mol Cancer"},{"key":"3382_CR54","doi-asserted-by":"publisher","first-page":"7770","DOI":"10.12659\/MSM.918486","volume":"25","author":"Z Dong","year":"2019","unstructured":"Dong Z, Sun X, Xu J, et al. Serum membrane type 1-matrix metalloproteinase (MT1-MMP) mRNA protected by exosomes as a potential biomarker for gastric cancer. Med Sci Monit. 2019;25:7770\u201383. https:\/\/doi.org\/10.12659\/MSM.918486.","journal-title":"Med Sci Monit"},{"issue":"1","key":"3382_CR55","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1186\/s12967-025-06955-9","volume":"23","author":"J Yang","year":"2025","unstructured":"Yang J, Han Y, Zeng B, et al. Epstein-Barr virus-coded miR-BART19-3p promotes proliferation of EBV-associated gastric cancer by inhibiting GADD45B. J Transl Med. 2025;23(1):956. https:\/\/doi.org\/10.1186\/s12967-025-06955-9.","journal-title":"J Transl Med"},{"issue":"14","key":"3382_CR56","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1128\/JVI.03159-12","volume":"87","author":"H Choi","year":"2013","unstructured":"Choi H, Lee H, Kim SR, et al. Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol. 2013;87(14):8135\u201344. https:\/\/doi.org\/10.1128\/JVI.03159-12.","journal-title":"J Virol"},{"issue":"10","key":"3382_CR57","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/ijc.31967","volume":"144","author":"O Ramayanti","year":"2019","unstructured":"Ramayanti O, Verkuijlen SAWM, Novianti P, et al. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV infections. Int J Cancer. 2019;144(10):2555\u201366. https:\/\/doi.org\/10.1002\/ijc.31967.","journal-title":"Int J Cancer"},{"issue":"4","key":"3382_CR58","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1002\/cam4.5269","volume":"12","author":"Q Li","year":"2023","unstructured":"Li Q, Lv M, Lv L, et al. Identifying HER2 from serum-derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab-based therapy. Cancer Med. 2023;12(4):4110\u201324. https:\/\/doi.org\/10.1002\/cam4.5269.","journal-title":"Cancer Med"},{"issue":"1","key":"3382_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","volume":"21","author":"DD Shen","year":"2022","unstructured":"Shen DD, Pang JR, Bi YP, et al. LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer. Mol Cancer. 2022;21(1):75. https:\/\/doi.org\/10.1186\/s12943-022-01557-1.","journal-title":"Mol Cancer"},{"key":"3382_CR60","doi-asserted-by":"publisher","first-page":"116182","DOI":"10.1016\/j.ejmech.2024.116182","volume":"268","author":"JG Sun","year":"2024","unstructured":"Sun JG, Gao Y, Gao Y, et al. Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer. Eur J Med Chem. 2024;268:116182. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116182.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"3382_CR61","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.isci.2023.108414","volume":"26","author":"J Wang","year":"2023","unstructured":"Wang J, Deng R, Chen S, et al. Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes. iScience. 2023;26(12):108414. https:\/\/doi.org\/10.1016\/j.isci.2023.108414.","journal-title":"iScience"},{"issue":"2","key":"3382_CR62","doi-asserted-by":"publisher","first-page":"e1802896","DOI":"10.1002\/adma.201802896","volume":"31","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J. Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater. 2019;31(2):e1802896. https:\/\/doi.org\/10.1002\/adma.201802896.","journal-title":"Adv Mater"},{"issue":"12","key":"3382_CR63","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41563-024-01961-6","volume":"23","author":"N Gong","year":"2024","unstructured":"Gong N, Zhong W, Alameh MG, et al. Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery. Nat Mater. 2024;23(12):1736\u201347. https:\/\/doi.org\/10.1038\/s41563-024-01961-6.","journal-title":"Nat Mater"},{"issue":"52","key":"3382_CR64","doi-asserted-by":"publisher","first-page":"e2201054","DOI":"10.1002\/adma.202201054","volume":"34","author":"T Yong","year":"2022","unstructured":"Yong T, Wei Z, Gan L, et al. Extracellular-vesicle-based drug delivery systems for enhanced antitumor therapies through modulating the cancer-immunity cycle. Adv Mater. 2022;34(52):e2201054. https:\/\/doi.org\/10.1002\/adma.202201054.","journal-title":"Adv Mater"},{"issue":"4","key":"3382_CR65","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11095-022-03224-y","volume":"40","author":"W Zeng","year":"2023","unstructured":"Zeng W, Wen Z, Chen H, et al. Exosomes as carriers for drug delivery in cancer therapy. Pharm Res. 2023;40(4):873\u201387. https:\/\/doi.org\/10.1007\/s11095-022-03224-y.","journal-title":"Pharm Res"},{"issue":"3","key":"3382_CR66","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cas.13488","volume":"109","author":"H Zhang","year":"2018","unstructured":"Zhang H, Wang Y, Bai M, et al. Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Sci. 2018;109(3):629\u201341. https:\/\/doi.org\/10.1111\/cas.13488.","journal-title":"Cancer Sci"},{"key":"3382_CR67","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2147\/IJN.S231214","volume":"15","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Zhang H, Ning T, et al. Exosome-delivered c-Met siRNA could reverse chemoresistance to cisplatin in gastric cancer. Int J Nanomed. 2020;15:2323\u201335. https:\/\/doi.org\/10.2147\/IJN.S231214.","journal-title":"Int J Nanomed"},{"key":"3382_CR68","doi-asserted-by":"publisher","first-page":"9862876","DOI":"10.34133\/2021\/9862876","volume":"2021","author":"Y Fan","year":"2021","unstructured":"Fan Y, Zhou Y, Lu M, et al. Responsive dual-targeting exosome as a drug carrier for combination cancer immunotherapy. Res (Wash D C). 2021;2021:9862876. https:\/\/doi.org\/10.34133\/2021\/9862876.","journal-title":"Res (Wash D C)"},{"key":"3382_CR69","doi-asserted-by":"publisher","first-page":"119606","DOI":"10.1016\/j.biomaterials.2019.119606","volume":"230","author":"S Pan","year":"2020","unstructured":"Pan S, Pei L, Zhang A, et al. Passion fruit-like exosome-PMA\/Au-BSA@Ce6 nanovehicles for real-time fluorescence imaging and enhanced targeted photodynamic therapy with deep penetration and superior retention behavior in tumor. Biomaterials. 2020;230:119606. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119606.","journal-title":"Biomaterials"},{"issue":"27","key":"3382_CR70","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1002\/smll.201600725","volume":"12","author":"YJ Chiu","year":"2016","unstructured":"Chiu YJ, Cai W, Shih YRV, et al. A single-cell assay for time lapse studies of exosome secretion and cell behaviors. Small. 2016;12(27):3658\u201366. https:\/\/doi.org\/10.1002\/smll.201600725.","journal-title":"Small"},{"key":"3382_CR71","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejps.2016.10.009","volume":"96","author":"C Charoenviriyakul","year":"2017","unstructured":"Charoenviriyakul C, Takahashi Y, Morishita M, et al. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci. 2017;96:316\u201322. https:\/\/doi.org\/10.1016\/j.ejps.2016.10.009.","journal-title":"Eur J Pharm Sci"},{"key":"3382_CR72","doi-asserted-by":"publisher","first-page":"25011","DOI":"10.3402\/jev.v3.25011","volume":"3","author":"DK Jeppesen","year":"2014","unstructured":"Jeppesen DK, Hvam ML, Primdahl-Bengtson B, et al. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. 2014;3:25011. https:\/\/doi.org\/10.3402\/jev.v3.25011.","journal-title":"J Extracell Vesicles"},{"key":"3382_CR73","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.2147\/IJN.S281890","volume":"15","author":"J Shao","year":"2020","unstructured":"Shao J, Zaro J, Shen Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int J Nanomed. 2020;15:9355\u201371. https:\/\/doi.org\/10.2147\/IJN.S281890.","journal-title":"Int J Nanomed"},{"issue":"4","key":"3382_CR74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1208\/s12248-018-0227-4","volume":"20","author":"S Ferguson","year":"2018","unstructured":"Ferguson S, Kim S, Lee C, et al. The phenotypic effects of exosomes secreted from distinct cellular sources: a comparative study based on miRNA composition. AAPS J. 2018;20(4):67. https:\/\/doi.org\/10.1208\/s12248-018-0227-4.","journal-title":"AAPS J"},{"key":"3382_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jconrel.2024.02.037","volume":"368","author":"JF Creeden","year":"2024","unstructured":"Creeden JF, Sevier J, Zhang JT, et al. Smart exosomes enhance PDAC targeted therapy. J Control Release. 2024;368:413\u201329. https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.037.","journal-title":"J Control Release"},{"key":"3382_CR76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","volume":"199","author":"T Smyth","year":"2015","unstructured":"Smyth T, Kullberg M, Malik N, et al. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015;199:145\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2014.12.013.","journal-title":"J Control Release"},{"key":"3382_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2015.10.017","volume":"98","author":"T Yamashita","year":"2016","unstructured":"Yamashita T, Takahashi Y, Nishikawa M, et al. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation. Eur J Pharm Biopharm. 2016;98:1\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2015.10.017.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3382_CR78","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/thno.38198","volume":"10","author":"Z Wan","year":"2020","unstructured":"Wan Z, Zhao L, Lu F, et al. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics. 2020;10(1):218\u201330. https:\/\/doi.org\/10.7150\/thno.38198.","journal-title":"Theranostics"},{"issue":"10","key":"3382_CR79","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1021\/acs.bioconjchem.9b00587","volume":"30","author":"S Shi","year":"2019","unstructured":"Shi S, Li T, Wen X, et al. Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention. Bioconjug Chem. 2019;30(10):2675\u201383. https:\/\/doi.org\/10.1021\/acs.bioconjchem.9b00587.","journal-title":"Bioconjug Chem"},{"issue":"4","key":"3382_CR80","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1567201819666220613150814","volume":"21","author":"ZY Guo","year":"2024","unstructured":"Guo ZY, Tang Y, Cheng YC. Exosomes as targeted delivery drug system: advances in exosome loading, surface functionalization and potential for clinical application. Curr Drug Deliv. 2024;21(4):473\u201387. https:\/\/doi.org\/10.2174\/1567201819666220613150814.","journal-title":"Curr Drug Deliv"},{"key":"3382_CR81","doi-asserted-by":"publisher","first-page":"216220","DOI":"10.1016\/j.canlet.2023.216220","volume":"565","author":"DN Moholkar","year":"2023","unstructured":"Moholkar DN, Kandimalla R, Gupta RC, et al. Advances in lipid-based carriers for cancer therapeutics: liposomes, exosomes and hybrid exosomes. Cancer Lett. 2023;565:216220. https:\/\/doi.org\/10.1016\/j.canlet.2023.216220.","journal-title":"Cancer Lett"},{"issue":"29","key":"3382_CR82","doi-asserted-by":"publisher","first-page":"18475","DOI":"10.1039\/D2RA02351B","volume":"12","author":"J Lee","year":"2022","unstructured":"Lee J, Lee J, Chakraborty K, et al. Exosome-based drug delivery systems and their therapeutic applications. RSC Adv. 2022;12(29):18475\u201392. https:\/\/doi.org\/10.1039\/D2RA02351B.","journal-title":"RSC Adv"},{"issue":"18","key":"3382_CR83","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.7150\/thno.27608","volume":"8","author":"QL Wang","year":"2018","unstructured":"Wang QL, Zhuang X, Sriwastva MK, et al. Blood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways. Theranostics. 2018;8(18):4912\u201324. https:\/\/doi.org\/10.7150\/thno.27608.","journal-title":"Theranostics"},{"key":"3382_CR84","doi-asserted-by":"publisher","first-page":"1608480","DOI":"10.3389\/fcell.2025.1608480","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Chen K, Liu W, et al. Engineered exosomes: a promising design platform for overcoming cancer therapy resistance. Front Cell Dev Biol. 2025;13:1608480. https:\/\/doi.org\/10.3389\/fcell.2025.1608480.","journal-title":"Front Cell Dev Biol"},{"issue":"16","key":"3382_CR85","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.3390\/ijms25168762","volume":"25","author":"JH Park","year":"2024","unstructured":"Park JH, Kim SJ, Kim OH, et al. Enhanced efficacy of gastric cancer treatment through targeted exosome delivery of 17-DMAG anticancer agent. Int J Mol Sci. 2024;25(16):8762. https:\/\/doi.org\/10.3390\/ijms25168762.","journal-title":"Int J Mol Sci"},{"issue":"29","key":"3382_CR86","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1039\/C8NR03970D","volume":"10","author":"A Longatti","year":"2018","unstructured":"Longatti A, Schindler C, Collinson A, et al. High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles. Nanoscale. 2018;10(29):14230\u201344. https:\/\/doi.org\/10.1039\/C8NR03970D.","journal-title":"Nanoscale"},{"issue":"6","key":"3382_CR87","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1136\/gutjnl-2024-333522","volume":"74","author":"ZR Cai","year":"2025","unstructured":"Cai ZR, Zheng YQ, Hu Y, et al. Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 2025;74(6):884\u201393. https:\/\/doi.org\/10.1136\/gutjnl-2024-333522.","journal-title":"Gut"},{"issue":"1","key":"3382_CR88","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41467-023-37403-1","volume":"14","author":"H Shin","year":"2023","unstructured":"Shin H, Choi BH, Shim O, et al. Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers. Nat Commun. 2023;14(1):1644. https:\/\/doi.org\/10.1038\/s41467-023-37403-1.","journal-title":"Nat Commun"},{"key":"3382_CR89","doi-asserted-by":"publisher","first-page":"116718","DOI":"10.1016\/j.bios.2024.116718","volume":"266","author":"X Lin","year":"2024","unstructured":"Lin X, Zhu J, Shen J, et al. Advances in exosome plasmonic sensing: device integration strategies and AI-aided diagnosis. Biosens Bioelectron. 2024;266:116718. https:\/\/doi.org\/10.1016\/j.bios.2024.116718.","journal-title":"Biosens Bioelectron"},{"issue":"42","key":"3382_CR90","doi-asserted-by":"publisher","first-page":"e10239","DOI":"10.1002\/adma.202510239","volume":"37","author":"H Bae","year":"2025","unstructured":"Bae H, Ji H, Konstantinov K, et al. Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery. Adv Mater. 2025;37(42):e10239. https:\/\/doi.org\/10.1002\/adma.202510239.","journal-title":"Adv Mater"},{"issue":"17","key":"3382_CR91","doi-asserted-by":"publisher","first-page":"12308","DOI":"10.1039\/D3CP00387F","volume":"25","author":"K Islam","year":"2023","unstructured":"Islam K, Razizadeh M, Liu Y. Coarse-grained molecular simulation of extracellular vesicle squeezing for drug loading. Phys Chem Chem Phys. 2023;25(17):12308\u201321. https:\/\/doi.org\/10.1039\/D3CP00387F.","journal-title":"Phys Chem Chem Phys"},{"issue":"12","key":"3382_CR92","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41568-021-00399-1","volume":"21","author":"O Elemento","year":"2021","unstructured":"Elemento O, Leslie C, Lundin J, Tourassi G. Artificial intelligence in cancer research, diagnosis and therapy. Nat Rev Cancer. 2021;21(12):747\u201352. https:\/\/doi.org\/10.1038\/s41568-021-00399-1.","journal-title":"Nat Rev Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03382-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:05Z","timestamp":1792096925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3382"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03382-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"272"}}